Complete financial analysis of Asahi Kasei Corporation (AHKSY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Asahi Kasei Corporation, a leading company in the Chemicals industry within the Basic Materials sector.
- Voyager Therapeutics, Inc. (VYGR) Income Statement Analysis – Financial Results
- United World Holding Group Ltd. (UWHGF) Income Statement Analysis – Financial Results
- eGuarantee, Inc. (EGTIF) Income Statement Analysis – Financial Results
- Medaro Mining Corp. (MEDA.CN) Income Statement Analysis – Financial Results
- Asahi Group Holdings, Ltd. (2502.T) Income Statement Analysis – Financial Results
Asahi Kasei Corporation (AHKSY)
About Asahi Kasei Corporation
Asahi Kasei Corporation manufactures, processes, and sells chemical products in Japan and internationally. The company operates through three segments: Material, Homes, and Health Care. It provides caustic soda, chemical fertilizers, nitric acid, ammonia, acrylonitrile, methyl methacrylate, styrene, adipic acid, hexamethylene diamine, AH salt, propionitrile, sodium cyanide, acetonitrile, methacrylonitrile, cyclohexyl methacrylate, cyclohexanol, cyclohexane, and cyclohexene; polymers; chemical intermediates; additives; membranes and systems; clads and anchors; optical and printing materials; electronic materials; and lithium-ion battery and lead-acid battery separators. The company offers cupro fiber, lining fabric, stretch fiber, spunbond nonwovens, cupro nonwoven fabric, microfiber suede, oil-water separator, multifunctional nonwoven, deodorizing nonwoven, heat-press formable thermoplastic nonwoven, noise suppression sheet, nylon filaments, flame-resistant fiber, honeycomb fabric, cellulose nanobead, ecorise, biocradle, and bemliese products, as well as polymers; synthetic rubber; elastomers; kitchen and household products; cleaners; and packaging products. In addition, the company provides electronic devices; and autoclaved aerated concrete, foundation systems, insulation materials, and structural systems and components. Further, it involved in the construction of homes and apartments; management of rental units and condominiums; brokerage of used homes; remodeling; and mortgage financing, asset management services, and insurance products. Additionally, the company provides pharmaceuticals and diagnostic reagents; dialyzers; therapeutic apheresis; biotherapeutics and plasma derivative filters and equipment, and virus removal filters; leukocyte reduction filters; defibrillators, temperature management systems, and data solutions; and UVC LED products. Asahi Kasei Corporation was founded in 1922 and is headquartered in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,784.88B | 2,726.49B | 2,461.32B | 2,106.05B | 2,151.65B | 2,170.40B | 2,042.22B | 1,882.99B | 1,940.91B | 1,986.41B | 1,897.77B | 1,666.64B |
| Cost of Revenue | 1,935.67B | 1,921.72B | 1,664.35B | 1,397.12B | 1,447.88B | 1,454.66B | 1,369.41B | 1,276.17B | 1,334.57B | 1,439.34B | 1,385.70B | 1,239.45B |
| Gross Profit | 849.21B | 804.77B | 796.97B | 708.93B | 703.76B | 715.75B | 672.80B | 606.83B | 606.34B | 547.06B | 512.06B | 427.19B |
| Gross Profit Ratio | 30.49% | 29.52% | 32.38% | 33.66% | 32.71% | 32.98% | 32.94% | 32.23% | 31.24% | 27.54% | 26.98% | 25.63% |
| Research & Development | 106.60B | 105.03B | 98.69B | 89.75B | 90.97B | 90.12B | 85.70B | 79.57B | 81.12B | 75.54B | 71.10B | 71.12B |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 374.68B | 350.06B | 330.58B | 323.23B | 295.14B | 280.05B | 249.03B |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.35B | 38.57B | 37.45B | 36.79B | 36.09B | 35.28B | 32.83B |
| SG&A | 601.87B | 571.39B | 495.63B | 447.37B | 435.53B | 416.04B | 388.63B | 368.03B | 360.02B | 331.23B | 315.33B | 281.86B |
| Other Expenses | 0.00 | -7.46B | -1.53B | -216.00M | -6.12B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 708.47B | 676.42B | 594.32B | 537.12B | 526.50B | 506.16B | 474.33B | 447.60B | 441.14B | 390.88B | 349.69B | 345.80B |
| Cost & Expenses | 2,644.13B | 2,598.13B | 2,258.67B | 1,934.24B | 1,974.38B | 1,960.82B | 1,843.74B | 1,723.76B | 1,775.71B | 1,830.22B | 1,735.40B | 1,585.25B |
| Interest Income | 7.68B | 3.90B | 1.36B | 1.90B | 2.77B | 3.09B | 2.08B | 1.43B | 1.42B | 2.26B | 1.49B | 911.00M |
| Interest Expense | 7.45B | 5.91B | 3.64B | 3.21B | 4.02B | 4.37B | 4.59B | 4.44B | 3.61B | 3.06B | 3.38B | 3.34B |
| Depreciation & Amortization | 182.20B | 177.29B | 148.13B | 133.27B | 118.30B | 104.05B | 113.46B | 109.19B | 109.63B | 95.22B | 94.64B | 86.81B |
| EBITDA | 218.49B | 305.00B | 350.78B | 287.39B | 278.25B | 313.63B | 311.94B | 268.42B | 274.84B | 253.15B | 237.99B | 178.77B |
| EBITDA Ratio | 7.85% | 11.19% | 14.25% | 14.49% | 13.74% | 14.45% | 15.27% | 14.26% | 14.16% | 12.74% | 12.54% | 10.73% |
| Operating Income | 140.75B | 128.35B | 202.65B | 171.81B | 177.26B | 209.59B | 198.48B | 159.23B | 165.20B | 157.93B | 143.35B | 91.96B |
| Operating Income Ratio | 5.05% | 4.71% | 8.23% | 8.16% | 8.24% | 9.66% | 9.72% | 8.46% | 8.51% | 7.95% | 7.55% | 5.52% |
| Total Other Income/Expenses | -111.90B | -189.62B | 12.48B | -20.90B | -21.33B | 809.00M | 19.86B | -1.84B | -18.81B | 507.00M | 20.51B | -9.66B |
| Income Before Tax | 28.84B | -61.91B | 215.12B | 150.91B | 155.93B | 210.40B | 218.33B | 157.39B | 146.39B | 158.44B | 163.86B | 82.30B |
| Income Before Tax Ratio | 1.04% | -2.27% | 8.74% | 7.17% | 7.25% | 9.69% | 10.69% | 8.36% | 7.54% | 7.98% | 8.63% | 4.94% |
| Income Tax Expense | -17.49B | 27.46B | 51.29B | 68.81B | 50.21B | 60.58B | 46.14B | 40.72B | 52.98B | 51.54B | 61.77B | 28.40B |
| Net Income | 43.81B | -91.31B | 161.88B | 79.77B | 103.93B | 147.51B | 170.25B | 115.00B | 91.75B | 105.65B | 101.30B | 53.71B |
| Net Income Ratio | 1.57% | -3.35% | 6.58% | 3.79% | 4.83% | 6.80% | 8.34% | 6.11% | 4.73% | 5.32% | 5.34% | 3.22% |
| EPS | 31.60 | -65.84 | 116.68 | 57.49 | 74.85 | 105.66 | 121.93 | 82.34 | 65.69 | 75.62 | 72.48 | 38.43 |
| EPS Diluted | 31.60 | -65.84 | 116.68 | 57.49 | 74.85 | 105.66 | 121.93 | 82.34 | 65.69 | 75.62 | 72.48 | 38.43 |
| Weighted Avg Shares Out | 1.39B | 1.39B | 1.39B | 1.39B | 1.39B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B |
| Weighted Avg Shares Out (Dil) | 1.39B | 1.39B | 1.39B | 1.39B | 1.39B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B |
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan
Asahi Kasei Bioprocess' Massachusetts Training Center Expands 2024 Course Offerings for Career Development and Industry Training
Asahi Kasei Microdevices Has Developed a Tiny Analog-to-Digital Converter for Smart Security Sensors That Features Integrated Glass-Break Detection for Only 34 μA
Sunrise CO2 Sensor from Asahi Kasei's Subsidiary, Senseair, Unveils New Technology at AHR 2024 for Energy Efficiency and Air Quality
Asahi Kasei acquires ISCC PLUS certification for several additional products
Asahi Kasei to Expand to the 3D Printing Market in North America Through Filament Sales
Asahi Kasei to Present Diversified Material Solutions for EV Batteries and Circular Economy at Fakuma 2023
Source: https://incomestatements.info
Category: Stock Reports